亚太地区在评估 HBV 患者的 HCC 风险和跨学科管理方面的注意事项
Asia-Pacific considerations in assessing HCC risk in patients with HBV and interdisciplinary management of HCC.
Patients achieving a functional cure for chronic hepatitis B with nucleos(t)ide analogue treatment may still develop HCC. What tools do we have to predict which patients will experience progression of liver disease?
HCC risk scores can inform a personalized approach to HCC surveillance in patients with chronic hepatitis B by allowing patients at very low risk to avoid burdensome surveillance and identifying high-risk patients who may benefit from intensive surveillance